课题基金 / 基金详情

Membrane-anchored growth factor shedding in tissue regeneration and repaire

Membrane-anchored growth factor shedding in tissue regeneration and repaire
组织再生和修复中膜锚定生长因子的脱落
批准号:
11670141
负责人:
HIGASHIYAMA Shigeki
金额:
$2.3万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
1999
资助国家:
日本
项目状态:
已结题
起止时间:
1999 至 2000

项目摘要

项目成果

HIGASHIYAMA Shigeki的其他基金

相似基金

相关文献

中文摘要
翻译
角质细胞的增殖和迁移对皮肤伤口愈合至关重要,部分是由表皮生长因子受体(EGFR)-配体相互作用以自分泌方式介导的。EGFR配体最初以膜锚定形式合成,但可以作为可溶性形式加工和脱落。我们在这里提供了证据(1),伤口刺激在体外诱导表皮生长因子受体配体的角质细胞脱落,特别是配体肝素结合的表皮生长因子样生长因子(HB-EGF)。由此产生的可溶性配体刺激了EGFR和信号转导分子Stat3(转录的信号传感器和激活因子3)的瞬时激活。OSU8-1是一种EGFR配体脱落抑制剂,在体外实验中可以消除伤口诱导的EGFR和Stat3的激活,抑制角质形成细胞的迁移。可溶性EGFR- fc能够中和所有EGFR配体,在体外也能抑制角质形成细胞的迁移。由于角化细胞迁移失败,OSU8-1应用于小鼠伤口部位大大延缓了再上皮化,但如果将重组可溶性HB-EGF与OSU8-1一起添加,则可以克服这种影响。这些发现表明,EGFR配体的脱落是角化细胞迁移的一个关键事件,并表明它们可能在伤口愈合的早期阶段作为一种有效的临床治疗方法。2)为了鉴定HB-EGF脱落酶,采用生物素化KB-R8301-Sepharose进行亲和层析。从人纤维肉瘤细胞系HT1080细胞的裂解液中纯化了3个rb - r8301结合蛋白。初步结构分析正在进行中。
英文摘要
Keratinocyte proliferation and migration are essential to cutaneous wound healing and are in part mediated in an autocrine fashion by *idermal growth factor receptor (EGFR)-ligand interactions. EGFR ligands are initially synthesized as membrane-anchored forms, but can be processed and shed as soluble forms. We provide evidence here (1) that wound stimuli induce keratinocyte shedding of EGFR ligands in vitro, particularly the ligand heparin-binding EGF-like growth factor (HB-EGF). The resulting soluble ligands stimulated transient activation of EGFR and the signal transduction molecule Stat3 (signal transducer and activator of transcription 3). OSU8-1, an inhibitor of EGFR ligand shedding, abrogated the wound-induced activation of EGFR and Stat3, and caused suppression of keratinocyte migration in vitro. Soluble EGFR-Fc, which is able to neutralize all EGFR ligands, also suppressed keratinocyte migration in vitro. The application of OSU8-1 to wound sites in mice greatly retarded reepithelialization as the result of a failure in keratinocyte migration, but this effect could be overcome if recombinant soluble HB-EGF was added along with OSU8-1. These findings indicate that the shedding of EGFR ligands represents a critical event in keratinocyte migration, and suggest their possible use as an effective clinical treatment in the early phases of wound healing. 2) In oreder to identify the HB-EGF shedding enzyme, affinity cplumn *romatography was carried using biotinylated KB-R8301-Sepharose. Three RB-R8301binding proteins were purified homogeneously from the lysate of a human fibrosarcoma cell line, HT1080 cells. Primary structure analyses of them are under going.
期刊论文(36)
专著(0)
科研奖励(0)
会议论文
Yokosaki,Y.,Higashiyama,S., et al.: "The integrina961 binds to a novel recognition sequence (SvvYGLR) in the thrombin-cleaved amono terminal fragment of osteopontin."J.Biol.Chem.. 274. 36328-36334 (1999)
Yokosaki,Y.,Higashiyama,S., et al.:“整合素 961 与骨桥蛋白凝血酶切割的氨基末端片段中的新识别序列 (SvvYGLR) 结合。”J.Biol.Chem.. 274. 36328-36334
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Koh,Y.H.,Higashiyama S., et al.: "Inactivation of glitathione peroxidase by No leads to the accumulation of H2O2 and the induction of HB-EGF via c-Jun NH2-terminal kinase in rat aortic smooth muscle cells."FASEB J.. (in press). (2001)
Koh,Y.H.,Higashiyama S., et al.:“No 灭活格列硫酮过氧化物酶会导致 H2O2 积累,并通过 c-Jun NH2 末端激酶在大鼠主动脉平滑肌细胞中诱导 HB-EGF。”FASEB J
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Yokosaki Y.,Higashiyama S.et al.: "The integrina 9bl binds to a novel recognition sequence (SVVYGLR) in the thrombin-cleaved amono terminal fragment of osteopontin"J. Biol. Chem.. 274. 36328-36334 (1999)
Yokosaki Y.、Higashiyama S.等人:“整合素 9bl 与骨桥蛋白凝血酶切割的氨基末端片段中的新识别序列 (SVVYGLR) 结合”。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Tokita,Y.,Higashiyama,S., et al.: "Regulation of neuregulin expression in the injured rat brain and cultured astrocytes."J.Neroscience.. 21. 1257-1264 (2001)
Tokita,Y.,Higashiyama,S.等人:“损伤大鼠脑和培养星形胶质细胞中神经调节蛋白表达的调节。”J.Neroscience.. 21. 1257-1264 (2001)
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
共 31 条
    Regulation of ectodomian shedding by ADAM17 and remnant signaling
    • 批准号:
      24390074
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $11.98万
    • 财政年份:
      2012
    • 负责人:
      HIGASHIYAMA Shigeki
    • 依托单位:
    Absolute Quantification of Transmembrane Protein Shedding and Its Application to the Monitoring of Chronic Inflammation
    • 批准号:
      24659280
    • 项目类别:
      Grant-in-Aid for Challenging Exploratory Research
    • 资助金额:
      $2.5万
    • 财政年份:
      2012
    • 负责人:
      HIGASHIYAMA Shigeki
    • 依托单位:
    Molecular mechanism of auto-translocation of membrane anchored EGFR ligand into the nuclear membrane and its diagnostic application of cancer
    • 批准号:
      22650228
    • 项目类别:
      Grant-in-Aid for Challenging Exploratory Research
    • 资助金额:
      $2.13万
    • 财政年份:
      2010
    • 负责人:
      HIGASHIYAMA Shigeki
    • 依托单位:
    Functional analysis of carboxy-terminal peptide signaling of pro-amphiregulin and pro-epiregulin
    • 批准号:
      20390082
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $12.48万
    • 财政年份:
      2008
    • 负责人:
      HIGASHIYAMA Shigeki
    • 依托单位:
    国内基金
    海外基金
    HB-EGF/EGFR信号介导的染色质重塑诱发OSF形成的作用及机制研究
    • 批准号:
      2025JJ50539
    • 项目类别:
      省市级项目
    • 资助金额:
      --
    • 批准年份:
      2025
    • 负责人:
      李宁
    • 依托单位:
    乙型肝炎病毒增强HB-EGF转录及m6A甲基化修饰促进血管生成
    • 批准号:
      82302503
    • 项目类别:
      青年科学基金项目
    • 资助金额:
      30万元
    • 批准年份:
      2023
    • 负责人:
      吴淑香
    • 依托单位:
    脱落酶ADAMDEC1通过HB-EGF形成正反馈环路促进类风湿关节炎血管新生的机制研究
    • 批准号:
      --
    • 项目类别:
      青年科学基金项目
    • 资助金额:
      30万元
    • 批准年份:
      2022
    • 负责人:
      邹玉明
    • 依托单位:
    CD9负调控HB-EGF/EGFR信号在创缘表皮细胞伪足形成中的作用与机制研究